FDA: Improved Artificial Heart Valve Approved

Share this content:
FDA: Improved Artificial Heart Valve Approved
FDA: Improved Artificial Heart Valve Approved

THURSDAY, June 18, 2015 (HealthDay News) -- The newest version of the Sapien 3 Transcatheter Heart Valve has been approved by the U.S. Food and Drug Administration.

The artificial valve is designed for patients with aortic valve stenosis. The product is sanctioned for people who are inoperable or at high risk for death or complications from open-heart surgery, the FDA said in a news release.

The newly approved device is the third-generation Sapien 3, originally approved in 2011. The newest version includes changes designed to minimize leakage, the FDA said. Possible side effects of the device itself include stroke, acute kidney injury, heart attack, bleeding, the need for a pacemaker, or death.

The device isn't recommended for people who can't tolerate anticoagulation/antiplatelet therapy, the agency said. The Sapien 3 is manufactured by Edwards Lifesciences, based in Irvine, Calif.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Bayer Stops U.S. Sale of Essure Birth Control Implant

Bayer Stops U.S. Sale of Essure Birth Control ...

Problems with device include chronic pain and perforations of the uterus and fallopian tubes

C.S. Mott Poll Addresses Child Safety at Amusement Parks

C.S. Mott Poll Addresses Child Safety at Amusement ...

2016 saw U.S. emergency departments deal with 30,000 injuries linked to amusement parks, carnivals

Greening Vacant Land Improves Neighborhood Mental Health

Greening Vacant Land Improves Neighborhood Mental Health

Cleaning up vacant lots in resource-limited urban settings can aid residents' mental health

is free, fast, and customized just for you!




Already a member?

Sign In Now »